Monitor for any future conversion of this 13G to a 13D, which would signal a shift from passive to activist intent. The large passive stake by a major index fund manager is routine and does not imply any imminent corporate action.
INO drugs
INO drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $1.45entry
- T+1 · 11d ago −16.21%α −16.52% · $1.22
- T+5 · 5d ago +0.69%α −2.60% · $1.46
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 15,364,105 shares of INOVIO PHARMACEUTICALS, INC. as of September 30, 2026, representing 14.5% of outstanding common stock. This is a routine passive stake update; the filing does not disclose the prior period's share count for comparison, so the direction of change cannot be determined from the documents provided.
Key Financial Metrics
Key Facts
- FMR LLC reported beneficial ownership of 15,364,105 shares of INOVIO common stock as of September 30, 2026.
- The stake represents 14.5% of outstanding shares.
- Fidelity Small Cap Growth Fund held 6,083,134 shares (5.8%) and Fidelity Small Cap Growth K6 Fund held 5,540,883 shares (5.2%) as of the same date.
- The filing is an amendment to Schedule 13G, indicating passive investment intent.
- No prior period share count is provided in the filing documents, so the change in position cannot be assessed.
Financial Impact
14.5% stake in a $172M market cap company, valued at approximately $24.9M based on the snapshot market cap.
Risk Factors
- No prior period comparison available in the filing documents; the direction of stake change is unknown.
- A passive 13G filing carries no presumption of activist intent; the investor has certified it is not seeking control.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002763 |
| Document: 0000315066-26-002763-index-headers.html | 0000315066-26-002763 |
| Document: 0000315066-26-002763-index.html | 0000315066-26-002763 |
| Document: 0000315066-26-002763.txt | 0000315066-26-002763 |
Track record
20 reports on INO
8 of 14 bullish or bearish reports moved the stock their way by T+5. Best: +46.23% at T+20 after the Jul 2, 2026 report. 9 of 15 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $1.39 Now $1.40 +0.72% settles Nov 24
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $1.40 Now $1.40 −0.01% settles Nov 24
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.41 Now $1.40 −0.71% settles Nov 23
- Nov 10, 20266d ago 8-K Bearish 5/10 Entry $1.48 Now $1.40 +5.08% settles Nov 18
- Nov 9, 20267d ago 8-K Bearish 5/10 Entry $1.51 to $1.40 Now $1.40 +7.28% ▲ +7.28% +5.59% vs SPY
- Nov 6, 202610d ago 424B5 Bearish 5/10 Entry $1.51 to $1.40 Now $1.40 +7.28% ▲ +7.28% +5.59% vs SPY
- Nov 5, 202611d ago Press Release Bearish 6/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
- Nov 5, 202611d ago 424B5 Bearish 4/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
- Nov 5, 202611d ago Press Release Bearish 4/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers